Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 30 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Narges C.

Iran

USD 30 /hr

Ph.D in medicinal chemistry | expert in Molecular docking, MD simulations & QSAR

Profile Summary

I am a PhD in Medicinal chemistry with a specialization in Computational Drug Discovery with extensive experience in molecular docking, molecular dynamics simulations, QSAR modeling, pharmacophore modeling, and cheminformatics. I help biotech companies, pharmaceutical startups, and researchers accelerate their drug discovery projects by providing high-quality, publication-ready computational analysis and reports. Services I provide: • Protein and ligand preparation • Molecular Docking • Molecular Dynamics Simulations • QSAR • ADMET & Drug-likeness analysis • Virtual screening • Structure/ligand based drug design • Professional reports with clear figures and interpretations I am available for remote, project-based collaborations with flexible deadlines and competitive pricing. My goal is to deliver accurate and actionable results that help my clients succeed in their research projects.

Subject Matter Expertise

• ☆ Molecular Modeling
• ☆ Molecular Docking
• ☆ Drug Discovery
• ☆ Medicinal Chemistry

Services

• Writing
• Research
• Data & AI

Writing Technical Writing

Research User Research, Scientific and Technical Research, Systematic Literature Review

Data & AI Predictive Modeling

Work Experience

researcher in Medicinal Chemistry/computational chemistry

Tabriz University of Medical Sciences

October 2023 - Present

Education

PhD in Structural Molecular and Computational Biology

Tabriz University of Medical Sciences

October 2016 - September 2022

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Narges Cheshmazar, Fereshteh Azimian, Narges Hosseini Nasab, Young Seok Eom, Rok Su Shim, Song Ja Kim, Mahrokh Dastmalchi, Siavoush Dastmalchi (2025). Structure–activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agents . BMC Chemistry.

Narges Cheshmazar, Maryam Hamzeh-Mivehroud, Salar Hemmati, Hoda Abolhasani, Fatemeh Heidari, Hojjatollah Nozad Charoudeh, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl, Siavoush Dastmalchi (2024). Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation . Future Medicinal Chemistry.

Narges Cheshmazar, Maryam Hamzeh-Mivehroud, Hojjatollah Nozad Charoudeh, Salar Hemmati, Jelena Melesina, Siavoush Dastmalchi (2022). Current trends in development of HDAC-based chemotherapeutics . Life Sciences.

Narges Cheshmazar, Salar Hemmati, Maryam Hamzeh-Mivehroud, Babak Sokouti, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl, Hojjatollah Nozad Charoudeh, Siavoush Dastmalchi (2022). Development of New Inhibitors of HDAC1–3 Enzymes Aided by <i>In Silico</i> Design Strategies . Journal of Chemical Information and Modeling.

Narges Cheshmazar, Siavoush Dastmalchi, Mineko Terao, Enrico Garattini, Maryam Hamzeh-Mivehroud (2019). Aldehyde oxidase at the crossroad of metabolism and preclinical screening . Drug Metabolism Reviews.